SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-18-004521
Filing Date
2018-04-30
Accepted
2018-04-30 16:01:18
Documents
5
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 PROXY NOTICE CARD finalregisterednoticecard.htm DEFA14A 14263
2 IMAGE finalregisterednoticecar000.jpg GRAPHIC 61835
3 IMAGE finalregisterednoticecar001.jpg GRAPHIC 98761
4 IMAGE finalregisterednoticecar002.jpg GRAPHIC 30312
5 IMAGE finalregisterednoticecar003.jpg GRAPHIC 14722
  Complete submission text file 0001654954-18-004521.txt   299368
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32639 | Film No.: 18789553
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences